Cargando…
Ovarian Cancer Stem Cells: A New Target for Cancer Therapy
Ovarian cancer is a highly lethal disease among all gynecologic malignancies and is the fifth leading cause of cancer-related death in women. Although the standard combination of surgery and chemotherapy was initially effective in patients with ovarian cancer, disease relapse commonly occurred due t...
Autores principales: | Zhan, Qinglei, Wang, Chunmei, Ngai, Saiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581273/ https://www.ncbi.nlm.nih.gov/pubmed/23509802 http://dx.doi.org/10.1155/2013/916819 |
Ejemplares similares
-
RuvBL2 Is Involved in Histone Deacetylase Inhibitor PCI-24781-Induced Cell Death in SK-N-DZ Neuroblastoma Cells
por: Zhan, Qinglei, et al.
Publicado: (2013) -
Ovarian cancer stem cells and targeted therapy
por: Keyvani, Vahideh, et al.
Publicado: (2019) -
Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020) -
Targeting ovarian cancer stem cells: a new way out
por: Ma, Huiying, et al.
Publicado: (2023) -
New perspectives on targeted therapy in ovarian cancer
por: Coward, Jermaine IG, et al.
Publicado: (2015)